| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/05/2004 | WO2004065864A1 Arrangement and operating method for monitoring air conditioning systems containing carbon dioxide as a coolant |
| 08/05/2004 | WO2004065633A1 Method of using peptidyl arginine deiminase type iv |
| 08/05/2004 | WO2004065626A2 A method of sepsis prognosis |
| 08/05/2004 | WO2004065624A1 Measuring device and method for the detection of dna sequence |
| 08/05/2004 | WO2004065622A1 Method of detecting drug resistance |
| 08/05/2004 | WO2004065616A2 Use of three-dimensional microfabricated tissue engineered systems for pharmacologic applications |
| 08/05/2004 | WO2004065602A1 Method of identifying the epithelial-mesenchymal transition of mesothelial cells (emtmc) and identifying emtmc-modulating compounds, pharmaceutical compositions and use thereof in the diagnosis and treatment of diseases associated with emtmc |
| 08/05/2004 | WO2004065599A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PROLIFERATION PRECURSOR CELL MARKER |
| 08/05/2004 | WO2004065569A2 Multi-functional antibodies |
| 08/05/2004 | WO2004065567A2 Brain progenitor cell-based assay, and related methods and compositions |
| 08/05/2004 | WO2004065562A2 Endocan compositions and methods for the treatment of neoplasms |
| 08/05/2004 | WO2004065560A2 Methods of screening for modulators of nerve growth factor |
| 08/05/2004 | WO2004065542A2 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 08/05/2004 | WO2004065491A1 Hydrophilic, thiol-reactive cyanine dyes and conjugates thereof with biomolecules for fluorescence diagnosis |
| 08/05/2004 | WO2004065422A2 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065421A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065420A1 Cancerous disease modifying antibodies |
| 08/05/2004 | WO2004065408A2 Enhancement of humoral immune responses using a novel myeloid accessory cell |
| 08/05/2004 | WO2004065404A1 Novel application of biosensors for diagnosis and treatment of disease |
| 08/05/2004 | WO2004065363A2 Computational design of a water-soluble analog of a protein, such as phospholamban and potassium channel kcsa |
| 08/05/2004 | WO2004065353A1 Compounds for the inhibition of rotamases |
| 08/05/2004 | WO2004065129A2 Electrochemical sensor having improved response time |
| 08/05/2004 | WO2004065015A2 Magnetic separator |
| 08/05/2004 | WO2004065009A1 Sample vessel for analyses |
| 08/05/2004 | WO2004064972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 08/05/2004 | WO2004064854A1 Method for enhancing learning and memory by suppressing the activity of ncx2 protein |
| 08/05/2004 | WO2004064822A1 Method of inhibiting prostate cancer cell proliferation |
| 08/05/2004 | WO2004064785A2 Cancer therapy sensitizer |
| 08/05/2004 | WO2004064783A2 Eosinophil-derived neurotoxin as a marker for ovarian cancer |
| 08/05/2004 | WO2004064773A2 Inhibition of e3-ubiquitin ligase hakai for treatment of proliferative disorders |
| 08/05/2004 | WO2004064770A2 Use of smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney |
| 08/05/2004 | WO2004064768A2 Animal model for alzheimer's disease |
| 08/05/2004 | WO2004064751A2 Nanoparticle based stabilization of ir fluorescent dyes |
| 08/05/2004 | WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms |
| 08/05/2004 | WO2004064740A2 Sperm specific lysozyme-like proteins |
| 08/05/2004 | WO2004064739A2 Substrate detection assay |
| 08/05/2004 | WO2004064736A2 Treatment of benign prostatic hyperplasia using energolytic agents |
| 08/05/2004 | WO2004064735A2 Treatment of benign prostatic hyperplasia |
| 08/05/2004 | WO2004064714A2 Animal model for obesity independently of insulin resistance |
| 08/05/2004 | WO2004064711A2 Modulation of deubiquitinase family members |
| 08/05/2004 | WO2004064710A2 Applications of substances binding to gstm for the diagnosis and treatment of cystic carcinomas |
| 08/05/2004 | WO2004064612A2 Regulation of tgf-b signaling by tomoregulin |
| 08/05/2004 | WO2004064594A2 Biochemical predictor test for obstetric cholestasis |
| 08/05/2004 | WO2004064479A2 Neuroprotective therapeutics and assays for identifying the same |
| 08/05/2004 | WO2004053769A9 A browsable database for biological use |
| 08/05/2004 | WO2004053484A3 Method for screening for agents preventing aggregation of potentially amyloidogenic proteins |
| 08/05/2004 | WO2004050869A8 PROTEIN BINDING TO Akt2 |
| 08/05/2004 | WO2004047049A3 Signature simulator |
| 08/05/2004 | WO2004046194A3 Polyclonal-monoclonal elisa assay for detecting n-terminus probnp |
| 08/05/2004 | WO2004043370A3 Methods and compositions for modulating activator protein 1 |
| 08/05/2004 | WO2004042359A3 Preformulation analysis and optimization |
| 08/05/2004 | WO2004036215A9 Diagnostic markers for therapeutic treatment |
| 08/05/2004 | WO2004029622A3 Antibody tools for the diagnostic use in the medical therapy with inhibitors of histone deacetylases |
| 08/05/2004 | WO2004029023A3 Cell-surface estrogen receptor and related compositions and methods |
| 08/05/2004 | WO2004027432A3 Prognostic methods for patients with prostatic disease |
| 08/05/2004 | WO2004025302A3 Method for the identification of proteins specific for renal cell carcinoma and use thereof |
| 08/05/2004 | WO2004024077A9 Novel composition and methods for the treatment of psoriasis |
| 08/05/2004 | WO2004022716A9 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 08/05/2004 | WO2004011938A3 Method and device for screening molecules in cells |
| 08/05/2004 | WO2004005465A3 Compositions and methods for the detection of human t cell receptor variable family gene expression |
| 08/05/2004 | WO2004003221A3 Methods for peptide-protein binding prediction |
| 08/05/2004 | WO2003102173A8 Protein or peptide (mimpd), nucleic acid that codes therefor, and uses of these substances |
| 08/05/2004 | WO2003102161A3 Methods of diagnosing & treating diabetes and insulin resistance |
| 08/05/2004 | WO2003099190A3 Serum transfer cup |
| 08/05/2004 | WO2003087342B1 Reducing non-specific binding in immunoassays performed on polymeric solid phases |
| 08/05/2004 | WO2003087054A3 Methods for identifying compounds that modulate enzymatic activity |
| 08/05/2004 | WO2003084465A3 Modeling biological systems |
| 08/05/2004 | WO2003081209A3 Identification of ligands for a receptor family and related methods |
| 08/05/2004 | WO2003058252A3 Test strip for determining concentration of multiple analytes in a single fluid sample |
| 08/05/2004 | WO2003054550A8 Uses of an endothelial cell receptor |
| 08/05/2004 | WO2003048729A3 Discovery of therapeutic products |
| 08/05/2004 | WO2003048383A3 Effectors of innate immunity |
| 08/05/2004 | WO2003042359A3 Histamine receptor h3 polynucleotides |
| 08/05/2004 | WO2003039462A3 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies |
| 08/05/2004 | WO2003029411A3 Novel cyclooxygenase variants and methods of use |
| 08/05/2004 | WO2003015768A3 Use of inhibitors of proline endopeptidase to modulate inositol (1,4,5) triphosphate concentration dependent on intracellular signal cascades |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | WO2002102976A3 Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571 |
| 08/05/2004 | WO2002095389A3 Method and detector for detecting gases |
| 08/05/2004 | WO2002043568A3 Identification of compounds that potentiate the activity of muscarinic potassium channels |
| 08/05/2004 | US20040154047 Rodent animal model for use in identifying modulators for treatment of familial alzheimer's disease; targeted gene therapy |
| 08/05/2004 | US20040153300 Signature simulator |
| 08/05/2004 | US20040153270 Quality monitoring system for building structure, quality monitoring method for building structure and semiconductor integrated circuit device |
| 08/05/2004 | US20040153256 Methods for crystallographic structure determination employing hydrogen exchange analysis |
| 08/05/2004 | US20040153255 Apparatus and method for encoding DNA sequence, and computer readable medium |
| 08/05/2004 | US20040153254 Method for the efficiency-corrected real-time quantification of nucleic acids |
| 08/05/2004 | US20040153252 System and method for integrated analysis of data for characterizing carbohydrate polymers |
| 08/05/2004 | US20040153251 Rearrangement of microarray scan images to form virtual arrays |
| 08/05/2004 | US20040153249 System, software and methods for biomarker identification |
| 08/05/2004 | US20040153001 Devices, methods and systems for collecting material from a breast duct |
| 08/05/2004 | US20040153000 Intra-vaginal self-administered cell collecting device and method |
| 08/05/2004 | US20040152994 Liver function test |
| 08/05/2004 | US20040152880 Compositions and methods for the reversible capture of biomolecules |
| 08/05/2004 | US20040152875 Novel purinergic receptor |
| 08/05/2004 | US20040152871 Comprises nucleotide sequences coding synoviolin polypeptide for identifying modulators for treatment of arthritic and inflammatory disorders |
| 08/05/2004 | US20040152658 For therapy of animal having a deficiency in a neuron's immediate early gene responsiveness to a stimulus |
| 08/05/2004 | US20040152648 Use of a pyruvate-kinase or a nucleic acid encoding a pyruvate-kinase as a target for the modulation of apoptosis |
| 08/05/2004 | US20040152626 Identification of novel splice variants of the human catalytic subunit cbeta of camp-dependent protein kinase and the use thereof |
| 08/05/2004 | US20040152250 Semiconductor wafer inspection system |
| 08/05/2004 | US20040152212 Using antibody fusion comprised of single chain nucleotide sequences, rolling circle amplification and surface plasmon resonance (SPR) to determine concentration of biomarker proteins in sample; cancer diagnosis |